Isoflavones: Their effects on cardiovascular risk and functions

Current Opinion in Lipidology

Volumn 14, Issue 1, 2003, Pages 3-8

  Nestel, Paul ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Isoflavones; Lipids; Pharmacokinetics; Vascular function

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY COMPLIANCE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; ESTROGEN ACTIVITY; HEART FUNCTION; HUMAN; NUTRIENT; PRIORITY JOURNAL; PUBLICATION; REVIEW;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; HEMODYNAMIC PROCESSES; HUMANS; ISOFLAVONES; RISK FACTORS;

EID: 0037312850     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200302000-00002     Document Type: Review

References (36)

1. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein on serum lipids. N Engl J Med 1995; 332:276-282.
2. Orouse JR, Morgan T, Terry JG, et al. A randomized trial comparing the effect of casein with soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999; 159:2070-2076.
3. Wangen KE, Duncan AM, Xu X, et al. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 2002; 73:225-231.
4. Teixeira SR, Potter SM, Weigel R, et al. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000; 71:1077-1084.
5. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hyoercholesterolemic, postmenopausal women. Am J Clin Nutr 1998; 68:545-551.
6. Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids and lipoproteins and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002; 76:78-84.
7. Erdman JD. Soy protein and cardiovascular disease. Circulation 2000; 102:2555-2559.
8. Clifton PM, Nestel PJ. Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus chiolesterol. Arterioscler Thromb 1992; 12:955-962.
9. Lichtenstein AH, Jalbert SM, Adkercreutz H, et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterelemic subjects. Arteriescler Thremb Vasc Biol 2002. Although soy protein lowered LDL-cholesterol moderately (by 5%) as compared with animal protein, this occurred irrespective of the amount of isoflavone and was limited to those with a raised LDL concentration.
10. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 2001; 73:728-735.
11. Teede HJ, Dalais FS, Kotsopoulos D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and post-menopausal women. J Clin Endocrinol Metab 2001; 86:3053-3060. This large trial of soy protein found a small reduction in the LDL: HDL ratio but found an improvement in some arterial functions also.
12. Meinertz H, Faergeman O, Nilausen K, et al. Effects of soy protein and casein in low cholesterol diets on plasma lipepreteins in normolipidemic subjects. Atherosclerosis 1988; 72:63-70.
13. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 2000; 71:1462-1469.
14. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997; 17:3392-3398.
15. Nestel PJ, Pomeros S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999; 84:895-898.
16. Simens LA, von Kenigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000; 85:1297-1301.
17. Hodgson JM, Puddey IB, Beilin LJ, et al. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentratiions: a randomized controlled trial in humans. J Nutr 1998; 128:728-732.
18. Howes JB, Sullivan D, Lai N, et al. The effects of dietary supplementation with isoflavones from red clover on lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000; 152:143-147.
19. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exptl Biol Med 1998; 217:335-339.
20. Nestel P, Teede H. The isoflavone biochanin lowers LDL-cholesterol in men [abstract]. Atheroscler Suppl 2002; 3:173.
21. Lovati MR, Manzoni C, Gianazza E, et al. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 2000; 130:2543-2549.
22. Setchell KDR. Phytoestrogens: the biochemistry, physiology and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68(suppl):1333S-1346S.
23. Brzozowski AM, Pike AC, Dauter Z, et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 1997; 389:753-758.
24. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28:576-582.
25. Walker HA, Dean TS, Sanders TAB. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation 2001; 103:258-262. This is the first demonstration in humans of a direct vasodilatory effect of genistein.
26. Chin-Dusting JPF, Fisher LJ, Lewis TV, et al. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol 2001; 133:595-605. This paper provides a pharmacological demonstration of the potent vasodilatory effects of isoflavone metabolites.
27. Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002; 163:339-347.
28. Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30:350-356.
29. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause mortality in hypertensive patients. J Hypertens 2000; 18:S20.
30. Waddell T, Dart AM, Medley TL, et al. Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension 2001; 38:927-931. This was the first demonstration that the severity of coronary atherosclerosis correlates with large arterial stiffness (inversely with systemic arterial compliance).
31. Hodgson JM, Puddey IB, Beilin LJ, et al. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels. Am J Hypertens 1999; 12:47-53.
32. Tikkanen MJ, Wahala K, Ojala S, et al. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95:3106-3110.
33. 2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000; 72:395-400.
34. Nagel SC, von Saal FS, Welshons WV. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 1998; 217:300-309.
35. Busby MG, Jeffcoat AR, Bloeden LT, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 2002; 75:126-136. Valuable data on complex pharmacokinetics of individual isoflavones is provided.
36. Tsunoda N, Pomeroy S, Nestel P. Absorption in humans of isoflavones from soy and red clover is similar. J Nutr 2002; 132:2199-2201.